DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrogen Corridor
Newsfile·2025-10-08 16:30

Core Points - DiagnaMed Holdings Corp. has signed a Memorandum of Understanding (MOU) with Quebec Innovative Materials Corp. and the Témiscamingue First Nation to advance natural hydrogen development along the Ontario-Quebec hydrogen corridor [1][2] - The partnership aims to combine advanced technology, environmental stewardship, and Indigenous knowledge to foster sustainable growth in Canada's clean natural hydrogen sector [2][5] Framework for Partnership and Collaboration - The MOU establishes a framework for cooperation among DiagnaMed, QIMC, and TFN, emphasizing transparency, respect, and mutual benefit [3] - The collaboration includes supporting TFN's participation in consultation, environmental monitoring, and community engagement related to natural hydrogen activities [3] - DiagnaMed and QIMC will provide in-kind support for TFN-led community projects, including equipment, materials, and technical expertise [3] Commitment to Responsible Innovation - The agreement signifies DiagnaMed's commitment to advancing clean energy technologies through collaboration with Indigenous communities [4] - The partnership recognizes TFN's cultural connection to the land and integrates Aboriginal Traditional Knowledge (ATK) into project design and environmental monitoring [4][5] - The initiative aims to create employment, training, and contracting opportunities for TFN members, supporting local economic development [4] About the Companies - Témiscamingue First Nation is an Algonquin community dedicated to protecting its lands and fostering sustainable economic development [6] - Quebec Innovative Materials Corp. focuses on exploring natural hydrogen and silica deposits, committed to sustainable practices and innovation [7] - DiagnaMed Holdings Corp. provides innovative solutions for the clean tech and life sciences industries [8]